Aspirin plays an amazing role in the treatment of bowel cancer

Share This Post

In previous studies, researchers have clarified how taking aspirin can help prevent bowel cancer. This study found that analgesics block key processes related to tumor formation. As we all know, regular aspirin can reduce the risk of colon cancer, but the anti-tumor properties of this drug are not fully understood.

Researchers at the University of Edinburgh are concerned with a structure called nucleolus found in cells. The activation of nucleoli causes tumor formation, and dysfunction is also associated with Alzheimer’s disease and Parkinson’s disease. A team from the University of Edinburgh Cancer Research Centre in the United Kingdom tested the effect of aspirin on laboratory-grown cells and tumor biopsies in patients with colon cancer.

They found that aspirin can block a key molecule called TIF-IA, which is a key molecule for nucleolus function.

Not all colon cancer patients respond to aspirin, but the researchers say their findings may help determine which ones are most likely to benefit.

Aspirin has side effects, including internal bleeding, which can cause certain types of stroke and is not recommended for long-term use. The researchers say the study paves the way for the development of new, safer therapies that mimic the effects of aspirin. The research was published in the journal Nucleic Acid Research and was funded by the Medical Research Council, Biotechnology and Biological Sciences Research Council. Worldwide cancer research, intestinal and cancer research, and the Rose Tree Trust also support this work.

Researchers at the Cancer Research Centre in Edinburgh, UK, said: “We are very excited about these findings because they proposed a mechanism for aspirin to prevent multiple diseases. By better understanding how aspirin prevents TIF-IA and nucleolar activity, Provides great hope for the development of new therapies and the development of targeted therapies.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy